back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-31 09:21 Tx date 2023-03-27 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,955
+5,000 vol $3.99 each |
15,000 | |
| Filed 2023-03-17 10:07 Tx date 2023-03-17 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-90,000 vol |
10,000 | |
| Filed 2023-03-17 10:02 Tx date 2023-02-01 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-90,000 vol |
||
| Filed 2022-12-15 15:25 Tx date 2022-12-12 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,000
+100,000 vol $0.41 each |
100,000 | |
| Filed 2022-12-15 15:08 Tx date 2022-03-02 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-04-10 21:24 Tx date 2020-04-10 |
$
Klinik Health Ventures Corp. |
Rusaw, Norla Nicole
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,983
+179,917 vol $0.20 each |
644,917 | |
| Filed 2019-12-03 12:52 Tx date 2019-12-03 |
$
Klinik Health Ventures Corp. |
Rusaw, Norla Nicole
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+465,000 vol $0.20 each |
465,000 | |
| Filed 2019-12-03 12:38 Tx date 2019-11-26 |
$
Klinik Health Ventures Corp. |
Rusaw, Norla Nicole
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-26 19:08 Tx date 2019-11-26 |
$
Klinik Health Ventures Corp. |
Rusaw, Norla Nicole
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2019-10-16 15:38 Tx date 2019-10-01 |
$NAB
Nabis Holdings Inc. (formerly, Innovative Properties Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+1,000,000 vol $0.10 each |
1,000,000 | |
| Filed 2019-10-16 15:36 Tx date 2019-10-01 |
$NAB
Nabis Holdings Inc. (formerly, Innovative Properties Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,900
+18,000 vol $3.55 each |
18,000 | |
| Filed 2018-03-28 Tx date 2017-08-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-14 Tx date 2015-08-12 |
$TTH
Transition Therapeutics Inc. |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-52,500
-15,000 vol $3.50 each |
192,193 | |
| Filed 2015-06-09 Tx date 2015-06-09 |
$TTH
Transition Therapeutics Inc. |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Holder: RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
1,000 | |
| Filed 2015-06-09 Tx date 2008-07-03 |
$TTH
Transition Therapeutics Inc. |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Holder: RESP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|